pyrroxamycin has been researched along with substance p in 1 studies
Studies (pyrroxamycin) | Trials (pyrroxamycin) | Recent Studies (post-2010) (pyrroxamycin) | Studies (substance p) | Trials (substance p) | Recent Studies (post-2010) (substance p) |
---|---|---|---|---|---|
9 | 0 | 1 | 17,289 | 277 | 2,010 |
Protein | Taxonomy | pyrroxamycin (IC50) | substance p (IC50) |
---|---|---|---|
Substance-P receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
Substance-K receptor | Rattus norvegicus (Norway rat) | 0.2 | |
Substance-K receptor | Homo sapiens (human) | 0.2455 | |
Substance-P receptor | Homo sapiens (human) | 0.0011 | |
Neuromedin-K receptor | Homo sapiens (human) | 0.125 | |
Substance-K receptor | Mesocricetus auratus (golden hamster) | 0.148 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hara, O; Hotta, K; Ishida-Okawara, A; Koyama, M; Masuda, K; Miyadoh, S; Mizuno, S; Suzuki, K | 1 |
1 other study(ies) available for pyrroxamycin and substance p
Article | Year |
---|---|
Pyrrolomycin group antibiotics inhibit substance P-induced release of myeloperoxidase from human polymorphonuclear leukocytes.
Topics: Actinomycetales; Anti-Bacterial Agents; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Neutrophils; Peroxidase; Pyrroles; Substance P | 1991 |